Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Senhwa Biosciences Logo
Senhwa Biosciences Growth Score
89
CB Rank
114514
Heat Score
52
Senhwa Biosciences is a biopharmaceutical company that develops novel small-molecule therapeutics for oncology and rare diseases.
Founded
obfuscation
PublicPost-IPO Equity Hsintien, T'ai-wan, Taiwan11-50 www.senhwabio.com
Biopharma
Biotechnology
Clinical Trials
Developer Platform
Health Care
Sustainability
Overview

Senhwa Biosciences
Total Funding
obfuscation
Growth Score
89
Heat Score
52

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score89
-6 pts
in past quarter
Heat Score 52
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Senhwa Biosciences

CB Rank
114514
Senhwa Biosciences is a biopharmaceutical company that develops novel small-molecule therapeutics for oncology and rare diseases.
Founded
obfuscation
PublicPost-IPO Equity Hsintien, T'ai-wan, Taiwan11-50 www.senhwabio.com
Biopharma
Biotechnology
Clinical Trials
Developer Platform
Health Care
Sustainability

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

  • Photo of Sarah Chang
    Sarah Chang: Executive Vice President and Chief Finance Officer
  • Photo of Jason Huang
    Jason Huang: Chief Medical Officer
    Past Role: Ascendo Biotechnology, CEO / CMO

Details

Legal Name Senhwa Biosciences, Inc.
Operating Status Active
Stock Symbol  TSX:6492
Company Type For Profit
Founders  Tai-Sen Soong
About the Company

Senhwa Biosciences identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Our central philosophy is to unearth validated targets or therapies that could significantly improve treatment, but have not yet been properly exploited. As a value-added development company, Senhwa aims to

take innovative therapies that could impact the current standard of care and drive them through to clinical proof-of-concept.

Phone Number +886 2 8911 9856
Contact Email service@senhwabio.com
Predictions & Insights

Growth Insight

See this Growth Insight
Senhwa Biosciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Silmitasertib (CX-4945)
A small molecule drug that inhibits Casein Kinase 2 (CK2) to treat cancer and shows antiviral activity against COVID-19 in vitro.
Pidnarulex (CX-5461)
A small molecule drug targeting DNA damage response pathways for cancer treatment, currently in clinical trials.

Research & Development

Senhwa Biosciences is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Senhwa Biosciences Logo
Post-IPO Equity - Senhwa Biosciences
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 7 Contacts 2

Employee Profiles

News

News and Press

News•May 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

961
-64.34%
 in past month

IT Spend

$56.1KThis year, Senhwa Biosciences is projected to spend $56.1K on IT, according to Aberdeen.

Actively Used Products

14Senhwa Biosciences uses 14 technology products and services including HTML5, Wordpress, and  Modernizr, according to G2 Stack.

Active Website Tech Count

42Senhwa Biosciences is actively using 42 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

30The intellectual property of Senhwa Biosciences includes 30 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Senhwa Biosciences's headquarters? Senhwa Biosciences is located in Hsintien, T'ai-wan, Taiwan.Who invested in Senhwa Biosciences? Senhwa Biosciences has 5 investors including The Global Emerging Markets Group and  WI Harper Group.When was the last funding round for Senhwa Biosciences? Senhwa Biosciences closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Senhwa Biosciences's competitors? Alternatives and possible competitors to Senhwa Biosciences may include Avenzo Therapeutics, Canton Strategic Holdings, and  Immuneering.How much funding has Senhwa Biosciences raised to date? Senhwa Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|